Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 316 entries
View as:

'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL

Phase: N/A Priority: Normal
NCT ID: NCT06833827 Org: User:
Start: 02/28/25 End: 01/31/29 Due: 01/31/30

Levosimendan Pharmacokinetics in Children

Phase: N/A Priority: Normal
NCT ID: NCT01704131 Org: User:
Start: 11/30/12 End: 09/01/19 Due: 09/01/20

One-visit Multi-site Intradermal Rabies Vaccination - Dose Finding

Phase: N/A Priority: Normal
NCT ID: NCT02276625 Org: User:
Start: 10/31/14 End: 02/29/16 Due: 02/28/17

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Phase: N/A Priority: Normal
NCT ID: NCT07021495 Org: User:
Start: 06/30/25 End: 12/31/29 Due: 12/31/30

Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)

Phase: N/A Priority: Normal
NCT ID: NCT04858867 Org: User:
Start: 01/10/22 End: 06/01/25 Due: 06/01/26

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05767879 Org: User:
Start: 01/01/22 End: 01/01/26 Due: 01/01/27

Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05235503 Org: User:
Start: 12/09/21 End: 06/30/23 Due: 06/30/24

EEG Theta-Beta Ratio Neurofeedback-training

Phase: N/A Priority: Normal
NCT ID: NCT02763618 Org: User:
Start: 02/29/16 End: 06/30/16 Due: 06/30/17

Effects of Caffeine on EEG Theta/Beta Ratio and Cognitive Control

Phase: N/A Priority: Normal
NCT ID: NCT02940808 Org: User:
Start: 05/31/16 End: 10/31/16 Due: 10/31/17

Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT01613794 Org: User:
Start: 12/31/12 End: 12/31/16 Due: 12/31/17

Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT03942887 Org: User:
Start: 05/03/19 End: 04/01/25 Due: 04/01/26

Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03811587 Org: User:
Start: 11/05/18 End: 08/06/21 Due: 08/06/22

SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia

Phase: N/A Priority: Normal
NCT ID: NCT06280690 Org: User:
Start: 01/31/24 End: 07/30/25 Due: 07/30/26

Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia

Phase: N/A Priority: Normal
NCT ID: NCT00539266 Org: User:
Start: 10/31/07 End: 10/31/12 Due: 10/31/13

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06179602 Org: User:
Start: 01/01/24 End: 01/01/28 Due: 01/01/29

Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT04748393 Org: User:
Start: 09/01/18 End: 02/01/21 Due: 02/01/22

Smoking Cessation Coaching in High-Risk Situations: A Virtual Reality Study

Phase: N/A Priority: Normal
NCT ID: NCT05654545 Org: User:
Start: 11/04/22 End: 04/19/23 Due: 04/19/24

SGM-101 in Colorectal Lung Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04737213 Org: User:
Start: 11/01/20 End: 12/01/21 Due: 12/01/22

Trial for the Diagnosis of Sarcoidosis

Phase: N/A Priority: Normal
NCT ID: NCT00872612 Org: User:
Start: 03/31/09 End: 05/31/12 Due: 05/31/13

Fludrocortisone and Information Processing in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01648998 Org: User:
Start: 05/31/12 End: 12/31/13 Due: 12/31/14

Longevity Families of the Netherlands

Phase: N/A Priority: Normal
NCT ID: NCT06374069 Org: User:
Start: 09/11/23 End: 12/31/26 Due: 12/31/27

Gastric Ultrasound Feeding Tube Placement Confirmation Study

Phase: N/A Priority: Normal
NCT ID: NCT06595537 Org: User:
Start: 12/18/23 End: 08/31/25 Due: 08/31/26

Early Migration in a High Congruent Rotating Platform Total Knee Prosthesis Design

Phase: N/A Priority: Normal
NCT ID: NCT01102829 Org: User:
Start: 09/30/07 End: 04/30/10 Due: 04/30/11

Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Phase: N/A Priority: Normal
NCT ID: NCT05393791 Org: User:
Start: 11/10/22 End: 11/10/27 Due: 11/10/28

Proactive Population Health Management of Cardiovascular Disease in Primary Care Using the PROSPERA-program.

Phase: N/A Priority: Normal
NCT ID: NCT06593704 Org: User:
Start: 10/09/24 End: 07/09/26 Due: 07/09/27